SEPTEMBER 2023LIFE SCIENCES REVIEW5Steven Henck, PhD, Vice President of R&D, Integrated DNA TechnologiesImproving Minimal ResidualDisease Detection Using NGS14Dr. Riikka Oksala,Director, DMPK & Safety Sciences, R&D,OrionImplementing Dose-Exposure-Response Information and Modern Tools in Drug Discovery?18Peter René Hesse, Vice President Head of Genomics Business, QIAGENUnlocking The Potential of Next-Generation Sequencing20Rachel Legmann, PhD., Senior Director of Technology, Gene Therapy, Repligen Corp.Gene Therapy--Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation22TJ Bing, Head of Biology, ICE Bioscience Inc.Unlocking the Future of Precision Medicine and Beyond24Marianthi Psacha, Global Head of Cell & Gene Therapy, Santen PharmaceuticalHow we're Leveraging New Technological Advancements by Building a Cell & Gene Therapy Business unit within an Established Pharmaceutical Company26FEATURED CompanYTOP 10SOLUTIONS PROVIDERS IN EUROPE - 2023Biotechdna Sequencing CXO INSIGHTSCXO INSIGHTSDr. Luciano Baielli, CEO16Cogentech
< Page 4 | Page 6 >